Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             163 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Activation of mature dendritic cells via PKC agonist induces HIV-1 reactivation of latently infected cells Benet, S.
3 S5 p. 10
 artikel
2 Adoptive T cell as a strategy for targeted delivery of immune checkpoint therapy Sung, J.
3 S5 p. 53
 artikel
3 A modified viral outgrowth assay incorporating ultra-sensitive P24 measurements Archin, N.
3 S5 p. 4
 artikel
4 A phase 2 trial to evaluate the effects of 3BNC117 in addition to antiretroviral therapy on the latent reservoir and viral rebound Lorenzi, J.
3 S5 p. 41
 artikel
5 Assessing antiretroviral drug (ARV) bioavailability in HIV tissue reservoirs using in vitro and in vivo pharmacokinetic (PK) studies with human primary lymphoid endothelial cells and mice Dyavar, S.
3 S5 p. 17
 artikel
6 Association between time spent with residual viremia after achievement of virological suppression and type of first-line antiretroviral regimen Lazzarin, A.
3 S5 p. 29
 artikel
7 Balancing risk-benefit ratio in donors of gut biopsy samples for HIV persistence research Routy, J.-P.
3 S5 p. 43
 artikel
8 BCL-2 inhibitor sensitizes the latent HIV reservoir to elimination by CTLs Huang, S.-H.
3 S5 p. 32
 artikel
9 Blinded evaluation of ultrasensitive assays of HIV in plasma Keating, S.M.
3 S5 p. 24-25
 artikel
10 Brain macrophages in SIV-infected ART-suppressed macaques represent a functional latent reservoir Clements, J.
3 S5 p. 8
 artikel
11 Brief ATI does not alter the size or composition of the latent HIV-1 reservoir Bar, K.J.
3 S5 p. 40-41
 artikel
12 Broadly neutraliing antibody cocktail prevents the establishment of viral reservoir against a mixed SHIV challenge Liu, P.-T.
3 S5 p. 17-18
 artikel
13 CD32+ CD4+ T Cells are HIV transcriptionally active rather than a resting reservoir Abdel-Mohsen, M.
3 S5 p. 9
 artikel
14 CD32 does not mark the HIV-1/SIV latent reservoir Osuna, C.E.
3 S5 p. 2
 artikel
15 CD4+ T-cell activation does not lead to expression of latent infection Kumar, N.A.
3 S5 p. 4
 artikel
16 CD4+ T cells expressing CD32 from HIV-1-positive patients are not enriched for proviral DNA Spivak, A.M.
3 S5 p. 8-9
 artikel
17 CD8 T cells from HIV positive individuals on ART have a skewed differentiation phenotype and impaired proliferative responses Clutton, G.
3 S5 p. 35
 artikel
18 Characterisation of immune exhaustion in natural killer cells and role in HIV infection Garrido, C.
3 S5 p. 37
 artikel
19 Characterizing HIV expression of proviruses during ART in tissues and blood McManus, W.R.
3 S5 p. 20
 artikel
20 Chronically treated HIV-positive subjects can naturally harbor extremely low viral reservoir Gálvez, C.
3 S5 p. 56-57
 artikel
21 Clonotypic differences in TCR reactivity to HIV-1 Gag TL9 in the context of HLA-B*42 and HLA-B*81 Anmole, G.
3 S5 p. 50-51
 artikel
22 Comparative transcriptome profiles in HIV-infected persons according to their clinical phenotype Psomas, C.K.
3 S5 p. 36-37
 artikel
23 CXCR3/CCR6 double positive germinal center T follicular helper cells (GC TFH) harbor residual virus during cART initiated during hyperacute HIV infection Ndhlovu, Z.
3 S5 p. 37
 artikel
24 Defining the landscape of HIV-specific T-cell responses in HIV-1 infected durably suppressed participants Warren, J.
3 S5 p. 39
 artikel
25 Defining the nature of protective CD8+ T-cell response in lymph nodes of HIV elite controllers Betts, M.
3 S5 p. 32
 artikel
26 Designing broad-spectrum gRNAs to target the HIV-1 LTR with CRISPR/cas9-based therapeutic strategies Allen, A.
3 S5 p. 50
 artikel
27 Determinants of early ART initiation during primary HIV infection: implications for HIV cure research Routy, J.-P.
3 S5 p. 43-44
 artikel
28 Developing an in vitro model for HIV-1 latency in Tfh cells using tonsillar tissue Luttge, B.
3 S5 p. 4
 artikel
29 Differences in the proviral HIV DNA between HIV monoinfected and HIV/HCV coinfected individuals Carrillo, M.S.
3 S5 p. 28
 artikel
30 Differential viral rebound between lymph node and colon after treatment interruption in SHIV-infected rhesus macaques Hsu, D.C.
3 S5 p. 15-16
 artikel
31 Direct and indirect effects of synthetic dual TLR-2 and TLR-7 agonists (Dual TLR-2/7) on latent HIV Macedo, A.B.
3 S5 p. 56
 artikel
32 Disease-specific HIV Nef identified in multiple patients with neurological disorders and cancers Lamers, S.
3 S5 p. 30
 artikel
33 Diverse interferons restrict HIV-1 Infection in macrophages through activation of SAMHD1 Szaniawski, M.
3 S5 p. 33
 artikel
34 DNA-PK regulates HIV transcription and latency by supporting the activity of RNA polymerase II and the recruitment of transcription machinery at HIV LTR Tyagi, M.
3 S5 p. 12-13
 artikel
35 Drug-induced modulation of cellular activation during latency reversal changes antigen processing and peptide presentation in primary CD4 T cells Boucau, J.
3 S5 p. 37-38
 artikel
36 Early lessons from shock and kill trials Søgaard, O.S.
3 S5 p. 47
 artikel
37 eCD4-Ig promotes ADCC activity of sera from HIV-1-infected patients Davis-Gardner, M.E.
3 S5 p. 49
 artikel
38 Effect of switching to integrase inhibitor on the HIV reservoir in ileum biopsies Moron-Lopez, S.
3 S5 p. 44-45
 artikel
39 Effect of tyrosine kinase inhibitors on the cytotoxic activity against HIV-1 infection Rodríguez-Mora, S.
3 S5 p. 51-52
 artikel
40 Effector memory T cells contribute to monotypic residual plasma virus production during long-term suppression Aamer, H.
3 S5 p. 27-28
 artikel
41 Enhancing infection-resistant cells for HIV cure in the non-human primate model Peterson, C.W.
3 S5 p. 14-15
 artikel
42 Enrichment of HIV proviral DNA from mononuclear leukocytes for next-generation sequencing of integration sites Williams-Wietzikoski, C.
3 S5 p. 23
 artikel
43 Evaluation of the in vivo capacity of broadly neutralising anti-HIV antibodies to eliminate latently infected cells from HIV-infected individuals using a novel humanised mouse model Flerin, N.
3 S5 p. 16-17
 artikel
44 Examining functional alterations of HIV-1 Tat variants associated with neurocognitively impaired patients in the Drexel Medicine CARES Cohort Nonnemacher, M.R.
3 S5 p. 24
 artikel
45 Follicular regulatory T cell dynamics in peripheral blood and lymphoid tissue during very early treatment initiation in HIV-1 clade C infection Laher, F.
3 S5 p. 31
 artikel
46 Fully MHC-matched allogeneic hematopoietic stem cell transplantation in SIV-infected, cART-suppressed Mauritian cynomolgus macaques indicates GVHD as a reservoir clearance mechanism Wu, H.L.
3 S5 p. 19
 artikel
47 Functional profiling of HIV-specific CTL clonotypes and their ability to reduce HIV reservoir Lima, N.
3 S5 p. 35
 artikel
48 Genetically intact but functionally impaired HIV-1 Env glycoproteins in the T-cell reservoir Verneuil, A.
3 S5 p. 28-29
 artikel
49 Genetic diversity and CTL escape burden in the replication-competent HIV reservoir in youth in a therapeutic HIV vaccine trial Brumme, Z.L.
3 S5 p. 26-27
 artikel
50 Genotypic and phenotypic characterization of replication-competent HIV clones from patients' reservoir Mammano, F.
3 S5 p. 25-26
 artikel
51 Gut and blood differ in mechanisms governing HIV transcription/latency Telwatte, S.
3 S5 p. 22
 artikel
52 Higher rectal p24 levels correlate with poor CD4 recovery in treated HIV infection Howell, B.J.
3 S5 p. 42
 artikel
53 High-throughput single-cell transcriptome analysis of immune cells from HIV-1 infected individuals before and after therapy Bradley, T.
3 S5 p. 31
 artikel
54 Histone lysine methyltransferases selectively restrict HIV in central memory T cells Dobrowolski, C.
3 S5 p. 5-6
 artikel
55 HIV antibody and T cell responses on ART are associated with HIV DNA but not RNA Keating, S.M.
3 S5 p. 33
 artikel
56 HIV-DNA, CD32a CD4+ T-cells and immune activation on successfull dolutegravir-based regimen Gantner, P.
3 S5 p. 30
 artikel
57 HIV integrates in genes regulating cell cycle, DNA damage, and viral transport Lee, S.
3 S5 p. 26
 artikel
58 HIV latency reversal using designed PKC modulators Marsden, M.D.
3 S5 p. 18
 artikel
59 HIV-1 mediated insertional activation of STAT5B and BACH2 promotes the formation of a viral reservoir in T regulatory cells Cesana, D.
3 S5 p. 20
 artikel
60 HIV-1 Nef dimeriation and AP-2 recruitment contribute to viral replication and T-cell loss in humanized mice Shu, S.
3 S5 p. 52-53
 artikel
61 HIV persistence in lymph nodes from virally suppressed individuals: residual production VS latency Pardons, M.
3 S5 p. 25
 artikel
62 HIV-1 populations can persist as active reservoirs in the CNS during ART treatment Joseph, S.B.
3 S5 p. 25
 artikel
63 HIV protease cleavage sites vaccine augments quality of T cell responses during ART Omange, R.W.
3 S5 p. 53-54
 artikel
64 HIV-1 proviruses which are integrated into cancer-related genes are inducible Varabyou, A.
3 S5 p. 1
 artikel
65 HIV-seroreversion dynamics after allogeneic stem cell transplantation Salgado, M.
3 S5 p. 40
 artikel
66 HIV-specific T cells expressing an X5-GPI artificial receptor can suppress hiv replication in vitro: implications for a cure strategy for HIV-positive individuals with hematologic malignancies Patel, S.
3 S5 p. 53
 artikel
67 HIV-specific T cells generated from HIV-naive adult and cord blood donors target a range of novel viral epitopes: implications for a cure strategy after allogeneic HSCT and CBT Patel, S.
3 S5 p. 55
 artikel
68 HIV viremia is the product of a small fraction of infected cells Anderson, E.
3 S5 p. 26
 artikel
69 Identification of a new factor involved in DNA methylation-mediated repression of latent HIV-1 Van Lint, C.
3 S5 p. 6
 artikel
70 Identification of a promising new class of latency reversing agents Gramatica, A.
3 S5 p. 1-2
 artikel
71 Identification of macrophage reservoirs through tropism of HIV-1 envelope Machado, V.
3 S5 p. 7
 artikel
72 Immunocapture identification of myeloid cell-derived HIV in CSF that is evolutionarily divergent from plasma virus Johnson, J.
3 S5 p. 42-43
 artikel
73 Impact of time of ART initiation on HIV specific T cell functionality in perinatally infected children Rinaldi, S.
3 S5 p. 38
 artikel
74 Improved HIV-1 clearance with BIT225 in the HIV-1 infected humanised mouse model Wilkinson, J.
3 S5 p. 47
 artikel
75 Increased expression and phosphorylation of SAMHD1 in SIV and HIV encephalitis is associated with proliferation of brain macrophages Lindgren, A.A.
3 S5 p. 13
 artikel
76 Index
3 S5 p. 60-64
 artikel
77 Infection of astrocytes by a virus isolated from CSF cells of an HIV-positive patient virologically suppressed with ART Li, G.
3 S5 p. 23
 artikel
78 Influence of sex as an intrinsic biological variable in a primary cell model of HIV latency Macedo, A.B.
3 S5 p. 19
 artikel
79 Insights into mechanisms of HIV reactivation from latency using RNA-Seq gene expression profiling in CD4+ T cells and their maturation subsets following treatment with latency reversing agents. Beliakova-Bethell, N.
3 S5 p. 3
 artikel
80 In situ multiplex RNA fluorescence imaging of SHIV1157ipd3N4 and anti-HIV CAR T cells to study CAR T cell trafficking to sites of viral reservoir in macaque lymphoid tissues Eichholz, K.
3 S5 p. 50
 artikel
81 Integration site-independent enhancement of latency reversal by HIV-1 Nef Kuang, X.T.
3 S5 p. 4
 artikel
82 Interim safety analysis of cancer immunotherapy trials Network – 12 (CITN-12): a Phase 1 study of pembrolizumab in patients with HIV and cancer Uldrick, T.S.
3 S5 p. 55-56
 artikel
83 Intrinsic resistance of HIV-infected macrophages to CTL-mediated killing drives immune activation Clayton, K.
3 S5 p. 36
 artikel
84 Intrinsic resistance of HIV-1 to SAMHD1 restriction permits efficient macrophage infection Plitnik, T.
3 S5 p. 22
 artikel
85 In vitro and in vivo quantification of HIV-induced neuroinflammation and effect of antiviral agents in primary human microglia and a murine HAND model Gavegnano, C.
3 S5 p. 18-19
 artikel
86 In vivo massive expansion of a T-cell clone carrying a defective HIV genome: implication for the measurement of the HIV reservoir Fromentin, R.
3 S5 p. 21-22
 artikel
87 In vivo suppression of HIV rebound by didehydro-Cortistatin A, a ‘block-and-lock’ strategy for HIV-1 cure Kessing, C.F.
3 S5 p. 47
 artikel
88 Lack of transcriptional latency in infected primary cells in the presence of exosomes and cART DeMarino, C.
3 S5 p. 11
 artikel
89 Lymph node CA-DNA strongly correlates with CD4+Tc count, plasma viral load and CD4/CD8 ratio during chronic HIV infection Salgado, G.
3 S5 p. 44
 artikel
90 Majority of the latent reservoir resides in CD32a negative CD4+ T cells Bertagnolli, L.N.
3 S5 p. 8
 artikel
91 Measurement and characterization of the latent reservoir for HIV-1 in patients receiving solid organ transplant Martin, A.
3 S5 p. 22-23
 artikel
92 Mobilizing NK cells for an HIV Cure: NK cells can target and kill latently HIV-1-infected primary T cells following proviral reactivation Checkley, M.
3 S5 p. 51
 artikel
93 Modeling the graft-versus-viral-reservoir effect in a nonhuman primate model of HIV persistence Peterson, C.W.
3 S5 p. 15
 artikel
94 Molecular characterisation of the inhibitor didehydro-Cortistatin A with the HIV-1 Tat protein Mediouni, S.
3 S5 p. 59
 artikel
95 Multiple NF-κB elements in the LTR of HIV-1 subtype C coordinate with the auto-regulatory circuit of Tat to drive rapid establishment of latency Chakraborty, S.
3 S5 p. 39
 artikel
96 Myeloid-derived suppressor cells decrease T-cell responses to viral antigens and therapeutic conserved elements DNA vaccine and increase following analytic treatment interruption Dross, S.
3 S5 p. 34
 artikel
97 Next generation viral outgrowth assays as proxies for classic QVOA to measure HIV-1 reservoir size Stone, M.
3 S5 p. 17
 artikel
98 No evidence for ongoing HIV replication in lymph nodes during suppressive ART McManus, W.R.
3 S5 p. 21
 artikel
99 No residual virus replication in a randomised trial of dolutegravir intensification Rasmussen, T.A.
3 S5 p. 41
 artikel
100 Novel dual role of dendritic cells in priming de novo CTL responses while inhibiting memory CTL responses to HIV-1 through the PD-L1 pathway Garcia-Bates, T.M.
3 S5 p. 36
 artikel
101 Novel mechanisms of baricitinib to block reservoir seeding and HIV persistence Kohler, J.
3 S5 p. 58
 artikel
102 Novel SHIVs encoding transmitted/founder envs for latency and cure research Bar, K.
3 S5 p. 18
 artikel
103 Novel use of alprazolam as a potential HIV-1 latency reversing agent Elbezanti, W.
3 S5 p. 52
 artikel
104 Oral ABX464 reduces the HIV DNA reservoir IN CD4+ peripheral blood T cells Steens, J.-M.
3 S5 p. 55
 artikel
105 Pacific biosciences small molecule real-time (SMRT) deep sequencing detects significant viral population structure in brain vs non-brain autopsy tissues from combined antiretroviral therapy (cART)-positive subjects Lamers, S.L.
3 S5 p. 29
 artikel
106 Partial control of viral rebound with a Rev-dependent lentiviral vector carrying HSV-tk gene in SIV-infected rhesus macaques Wu, Y.
3 S5 p. 56
 artikel
107 Patient-derived HIV reservoirs can be stably engrafted into NSG mice and reactivated by latency-reversing agents in vivo Ward, A.
3 S5 p. 15
 artikel
108 Persistence of antigen presenting cell-mediated HIV trans infection during cART Rappocciolo, G.
3 S5 p. 38
 artikel
109 Persistence of CD4+PD-1 high T cells despite long-term suppressive ART Macatangay, B.
3 S5 p. 35-36
 artikel
110 Persistence of SIV in the brain of SIV-infected Chinese rhesus macaques with or without antiretroviral therapy Ling, B.
3 S5 p. 15-16
 artikel
111 Platelets from HIV-infected cART-treated patients carry infectious viruses and predict poor immunological recovery Bomsel, M.
3 S5 p. 31
 artikel
112 Preclinical development of a bispecific HIV x CD3 DART molecule that redirects T cells to kill HIV envelope (env)-expressing cells Nordstrom, J.L.
3 S5 p. 48-49
 artikel
113 Preservation of IL-17 producing γδ T cells and their role in the control of immune activation in HIV controllers: ANRS EP56 study Weiss, L.
3 S5 p. 38
 artikel
114 Productive HIV-1 infection upregulates CD32 in vitro and in vivo Serra Peinado, C.
3 S5 p. 20-21
 artikel
115 Properties of eCD4-Ig relevant to reducing the viral reservior Farzan, M.
3 S5 p. 47-48
 artikel
116 Quantification of undetectable plasma HIV RNA Margot, N.
3 S5 p. 45
 artikel
117 Quantitation of the CD4+ T cell and macrophage reservoirs in SIV-infected ART-suppressed macaques: two functional latent reservoirs Clements, J.
3 S5 p. 11
 artikel
118 QVOA coupled with digital p24 analysis enhances HIV reservoir quantification Wonderlich, E.R.
3 S5 p. 10
 artikel
119 Rapid antiretroviral therapy of blood donors with acute and recent HIV infection: a preliminary report from the Monitoring and Acute Treatment of HIV Study (MATHS) van den Berg, K.
3 S5 p. 44
 artikel
120 Re-evaluating the peptide repertoire of MHC-E Brackenridge, S.
3 S5 p. 49-50
 artikel
121 Regulation of HIV-1 provirus and CD4+ T cell biology by transcriptional coregulators Nikolai, B.C.
3 S5 p. 4
 artikel
122 Regulation of HIV-1 replication by Poly (ADP-ribose) polymerase-1 in CD4 T cells. Llano, M.
3 S5 p. 4
 artikel
123 Replicate Aptima VL testing detects residual viremia in most ART-treated adults Bakkour, S.
3 S5 p. 23-24
 artikel
124 Retinoic acid (RA) upregulates α4β7 on CD4+ T cells and activates latent reservoirs Omalla, O.A.
3 S5 p. 33
 artikel
125 Role of mitochondrial antiviral signaling protein in reactivation of latent HIV-1 in CD4+ T cells Novis, C.L.
3 S5 p. 58
 artikel
126 Safety and potential impact of auranofin on the viral reservoir in HIV positive individuals under mega-ART Diaz, R.S.
3 S5 p. 43
 artikel
127 Sequencing HIV proviruses over time provides new insights into reservoir decay VanBelzen, D.J.
3 S5 p. 40
 artikel
128 Single cell analysis of HIV latency reveals diverse proviral and host cell behaviour Browne, E.P.
3 S5 p. 2
 artikel
129 Single-cell RNA-Seq reveals transcriptional heterogeneity in latent and reactivated HIV-infected cells Golumbeanu, M.
3 S5 p. 3
 artikel
130 Single-cell transcriptomics to evaluate HIV latency establishment in primary CD4 T cells De Armas, L.
3 S5 p. 11
 artikel
131 Single romidepsin infusions do not increase HIV expression in persons on ART (A5315) McMahon, D.
3 S5 p. 41-42
 artikel
132 SIV persists in lymphoid tissues despite alemtuzumab-induced CD4+ T cell depletion Okoye, A.A.
3 S5 p. 15-16
 artikel
133 SIV proviral landscape differs from that of HIV-1 and shows gross hypermutation Murray, A.J.
3 S5 p. 13
 artikel
134 SIV-specific CD8 T cells are largely excluded from B cell follicles during early SIV infection Li, S.
3 S5 p. 34
 artikel
135 SMAC mimetics are potent latency reversal agents with single agent and combination activity ex vivo Dunham, R.M.
3 S5 p. 52
 artikel
136 SMAC mimetics reverse HIV latency by selective activation of the non-canonical NF-κB pathway Sampey, G.C.
3 S5 p. 51
 artikel
137 Spread of HIV-DNA in CD4+ T-cells subsets depends on ART initiation timing Gantner, P.
3 S5 p. 29-30
 artikel
138 Stimulating cellular locomotion using α1PI therapy to eradicate reservoirs without adverse effects Bristow, C.
3 S5 p. 45-46
 artikel
139 Susceptibility to neutralization by bnAbs orrelates with infected cell binding for a panel of clade B HIV reactivated from latent reservoirs Ren, Y.
3 S5 p. 32-33
 artikel
140 Synergistic HIV latency reversal from an in vitro screen of epigenetic and kinase inhibitors Irlbeck, D.
3 S5 p. 58
 artikel
141 Targeted screens identify new chromatin regulators of HIV latency Turner, A.-M.
3 S5 p. 10
 artikel
142 T-cell signaling pathways leading to reactivation of P-TEFb and HIV transcription elongation in resting memory T cells Mbonye, U.
3 S5 p. 12-13
 artikel
143 TCF-1 expression is associated with HIV-specific CD8+ T cell proliferative capacity Rutishauser, R.
3 S5 p. 34
 artikel
144 Temporary ART initiated during primary HIV-1 infection limits the viral reservoir but increases virus diversity upon therapy interruption Verschoor, Y.L.
3 S5 p. 28
 artikel
145 Testing cure approaches in NHPs: the Emory experience Silvestri, G.
3 S5 p. 14
 artikel
146 The CCR5-agonist maraviroc reverses HIV latency, results from ex vivo studies and a randomized placebo controlled clinical trial Symons, J.
3 S5 p. 42
 artikel
147 The contribution of memory CD4+ T cell subset phenotype to latency reversal efficiency Kulpa, D.A.
3 S5 p. 1
 artikel
148 The critical importance of social sciences in early-phase HIV cure research: what's in it for biomedical HIV cure scientists? Dube, K.
3 S5 p. 45
 artikel
149 The genetic traits of full-length HIV sequenced from memory T cell subsets Horsburgh, B.A.
3 S5 p. 13
 artikel
150 The HIV-1 antisense transcript AST recruits the polycomb repressor complex 2 to the HIV-1 5’LTR and acts as a viral latency factor Romerio, F.
3 S5 p. 8
 artikel
151 The human IL-15 superagonist complex ALT-803 drives SIV-specific CD8+ T cells into B cell follicles Webb, G.
3 S5 p. 48
 artikel
152 The impact of ART duration on the infection of T cells within anatomic sites Lee, E.
3 S5 p. 9
 artikel
153 The latent reservoir as a genetically diverse archive recapitulating within-host HIV evolutionary history Jones, B.
3 S5 p. 27
 artikel
154 Therapeutic efficacy of optimized eCD4-Ig proteins in SHIV-infected rhesus macaques Gardner, M.R.
3 S5 p. 49
 artikel
155 The role of APOBEC 3G/3F in shaping early HIV-1 reservoir landscapes Reddy, K.
3 S5 p. 27
 artikel
156 Tissue macrophages are a major viral reservoir in male urethra of HIV-1-infected individuals under suppressive antiretroviral therapy Bomsel, M.
3 S5 p. 21
 artikel
157 Treatment with native heterodimeric IL-15 increases cytotoxic lymphocytes in lymph nodes and reduces SHIV RNA Pavlakis, G.
3 S5 p. 48
 artikel
158 Understanding persistence of the latent reservoir Siliciano, R.F.
3 S5 p. 1
 artikel
159 Upregulation of the Nrf2 antioxidant pathway characterizes the transition from productive to latent infection in CD4+ T cells Shytaj, I.
3 S5 p. 6-7
 artikel
160 Using barcoded HIV-1 to understand inducibility of the latent HIV-1 reservoir Larragoite, E.
3 S5 p. 13
 artikel
161 Validation of an unbiased screen method for the identification of secondary fungal metabolites reversing HIV-1 latency Stoszko, M.
3 S5 p. 59
 artikel
162 Visualization and quantification of HIV dissemination and reservoirs using in vivo imaging Young, W.-B.
3 S5 p. 14
 artikel
163 Whole genome sequencing of single HIV provirus and its proviral integration site for the study of HIV latency Sun, C.
3 S5 p. 3-4
 artikel
                             163 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland